Clinical trial No longer in our active list Interventional Ages 3 Months to 18

Using integrons to guide antibiotic treatment for urinary tract infections in children

Official title: INterest of the Negative Predictive Value of Integrons in Choosing a Narrow-spectrum Empirical anTibiotic Treatment vs Usual Empirical Antibiotic Treatment for Urinary Tract infectionS in the PEDiatric Emergency Department

Run by University Hospital, Limoges · NCT05066854 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing if using a special urine test to guide antibiotic treatment can help children with urinary tract infections just as well as the usual antibiotics, while also helping to reduce antibiotic resistance.

Quick facts

Study typeInterventional
Ages3 Months to 18 Years
SexAll
Enrollment232 (estimated)
SponsorUniversity Hospital, Limoges
Academic / other
Drugs / interventionsmethotrexate
Locations4 sites (Bordeaux and 3 other locations)
Trial IDNCT05066854 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 3 months to 18 years with a first episode of urinary tract infection with fever.

Probably not a fit

Patients with severe infections, dehydration, or anatomical defects of the urinary tract may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of using integron detection in urine samples to guide antibiotic treatment for children with non-severe urinary tract infections (UTIs) presenting to pediatric emergency departments. The primary objective is to demonstrate that an empirical treatment based on integron results is non-inferior to standard antibiotic treatment recommended by guidelines. By potentially allowing the use of trimethoprim-sulfamethoxazole instead of broader-spectrum antibiotics, the study seeks to reduce antibiotic resistance. The study will compare two treatment strategies: the usual practice and the integron-guided approach.

Why it matters

Potential benefit: If successful, this approach could lead to more targeted antibiotic treatments, reducing the risk of antibiotic resistance in children.

How similar studies have gone: Preliminary studies have shown promising results with integron detection, indicating potential for success in this novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children above 3 months old and under 18 years old
* Consultation in a participating pediatric emergency department
* Suspicion of UTI with fever (Fever ≥ 38°C and urine dipstick test positive for leukocytes and/or nitrites)
* First episode of UTI with fever
* Written informed consent of the holders of parental authority
* Affiliated to Social Security

Exclusion Criteria:

* Criteria of severity:

  * Severe infection with severe sepsis or septic shock
  * Dehydration ≥ 10%
  * Fever ≥ 38°C \> 4 days (96h)
  * Indication of surgical or interventional drainage
* Complication risk factors:

  * Any anatomic or functional defect of the urinary tract (other than low-grade VUR and calyceal dilation \< 10 mm)
  * Repetition of UTI with fever ≤ than 6 months since the previous episode
  * Repetition of UTI with fever and anatomic or functional defect of the urinary tract
  * Pregnancy
  * Severely immunocompromised patient
  * Severe chronic renal failure defined as a clearance \< 30 mL/min/1.73 m2
  * Severe liver failure
* 3GC allergy
* Contra-indication to SXT:

  * G6PD deficiency
  * Treatment with methotrexate
  * Allergy to sulfonamide
* Antibiotic treatment within 48h before admission
* Empirical antibiotic treatment not recommended

Where it's running

  • Bordeaux university Hospital
    Bordeaux, France
    Recruiting
  • Limoges university Hospital
    Limoges, France
    Recruiting
  • Montpellier university Hospital
    Montpellier, France
    Recruiting
  • Toulouse university Hospital
    Toulouse, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Understanding how drugs work in children

    This study is trying to find the best and safest doses of certain medications for children and young adults under 21 who are being treated for conditions like COVID-19 and pulmonary arterial hypertension.

    Recruiting at 5 sites Duke University · Phoenix, Arizona and 51 other locations · NCT04278404

  • Digestive tract effects after common antibiotics for urinary infections in young children

    This project will see if common antibiotic treatments for febrile urinary tract infections in children under 3 change their gut bacteria or increase antibiotic-resistant strains.

    Recruiting at 14 sites Centre Hospitalier Intercommunal Creteil · Charenton-le-Pont and 19 other locations · NCT03825874

  • Using integron tests to guide first-line antibiotics for non-severe UTI in adults

    This trial tests whether detecting integrons in urine can help doctors choose appropriate antibiotics for adults with non-severe urinary tract infections who had a resistant gram-negative infection in the past.

    Recruiting University Hospital, Limoges · Chambray-lès-Tours and 6 other locations · NCT07675018

  • B Lymphocyte Populations in the Lungs of ICU Patients on Ventilation

    This study tests the presence and roles of B lymphocytes in the lungs of adults on invasive ventilation, to see how humoral immunity relates to ventilator-associated pneumonia.

    Recruiting University Hospital, Limoges · Limoges · NCT07436780

  • Diffusion in the growing spine: ADC of the intervertebral disc in children

    This study tests whether MRI diffusion measurements in the intervertebral disc can help understand differences between scoliotic and healthy children.

    Recruiting University Hospital, Limoges · Limoges and 1 other locations · NCT07331298

  • Identifying harmful IgA in IgA-related kidney disease

    This project will test whether specific forms of IgA in adults with IgA nephropathy or IgA vasculitis cause kidney damage by analyzing blood and biopsy samples.

    Recruiting University Hospital, Limoges · Limoges · NCT07295808

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.